Rapid-Onset Psychotic Symptoms After Interferon-β-1a Treatment of Multiple Sclerosis

被引：0
|
作者：
Huang, Jing-Syuan [1 ,2 ]
Chang, Chuan-Chia [2 ]
Tai, Yueh-Ming [1 ,2 ]
Huang, Chien-Peng [3 ]
Chen, Shyi-Jou [4 ]
Tzeng, Nian-Sheng [2 ,5 ]
机构：
[1] Triserv Gen Hosp, Natl Def Med Ctr, Beitou Branch, Dept Psychiat, Taipei, Taiwan
[2] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan
[3] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pathol, Taipei, Taiwan
[4] Triserv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Pediat, Taipei, Taiwan
[5] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2020年 / 27卷 / 06期
关键词：
IFN-BETA-1A; THERAPY; PATIENT;
D O I：
10.1097/MJT.0000000000001017
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
下载
收藏
页码：E627 / E629
页数：4
相关论文
共 50 条
  • [1] Interferon-β1a for the treatment of multiple sclerosis
    Clerico, Marinella
    Contessa, Giulia
    Durelli, Luca
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (04) : 535 - 542
  • [2] Rapid onset of ulcerative colitis after treatment with interferon β1a in a patient with multiple sclerosis
    Tuna, Yasar
    Basar, Omer
    Dikici, Hilmi
    Koklu, Seyfettin
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (01): : 75 - 76
  • [3] Early administration of interferon-β-1a in multiple sclerosis
    European Journal of Pediatrics, 2001, 160 (2) : B135 - B136
  • [4] Early administration of interferon-β-1a in multiple sclerosis
    不详
    EUROPEAN JOURNAL OF PEDIATRICS, 2001, 160 (02) : 135 - 136
  • [5] Quality of life in multiple sclerosis:: influence of interferon-β1a (Avonex®) treatment
    Vermersch, P
    de Seze, J
    Delisse, B
    Lamaire, S
    Stojkovic, T
    MULTIPLE SCLEROSIS JOURNAL, 2002, 8 (05) : 377 - 381
  • [6] PEGylation of Interferon-β-1a A Promising Strategy in Multiple Sclerosis
    Kieseier, Bernd C.
    Calabresi, Peter A.
    CNS DRUGS, 2012, 26 (03) : 205 - 214
  • [7] Interferon-β treatment in patients with childhood onset multiple sclerosis
    Mikaelloff, Y
    Moreau, T
    Debouverie, M
    Pelletier, J
    Lebrun, C
    Gout, O
    Pedespan, JM
    Van Hulle, C
    Vermersch, P
    Ponsot, G
    JOURNAL OF PEDIATRICS, 2001, 139 (03): : 443 - 446
  • [8] ECONOMIC EVALUATION OF FINGOLIMOD COMPARED TO INTERFERON-β1A IN THE TREATMENT OF PEDIATRIC-ONSET MULTIPLE SCLEROSIS (POMS) IN MEXICO
    Tierrablanca, L.
    Gonzalez, L. A.
    Botello, B. S.
    Gomar, D.
    VALUE IN HEALTH, 2020, 23 : S266 - S267
  • [9] Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada
    Nakhaipour, Hamid Reza
    Vudumula, Umakanth
    Khurana, Vivek
    Sebire, Guillaume
    Mah, Jean K.
    Pohl, Daniela
    Schecter, Robyn
    Adlard, Nicholas
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (12) : 1525 - 1533
  • [10] Changes in plasma cytokines induced by interferon-β1a treatment in patients with multiple sclerosis
    Duddy, ME
    Armstrong, MA
    Crockard, AD
    Hawkins, SA
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (01) : 98 - 109
12345